Covirix shareholders are expected to hold approximately 85.8% of Newgen's shares in Newgenivf Group Limited.
Newgenivf集团有限公司：Covirix股东预计持有Newgen约85.8%的股权。
Covirix shareholders are expected to hold approximately 85.8% of Newgen's shares in Newgenivf Group Limited.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.